4
Changes in Ownership
Pacira BioSciences, Inc. Filed Acc 0001628280-26-027287
Chief Financial Officer sold 12,941 shares at $25.16 ($325,596)
- Chief Financial Officer acquired 12,941 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cross Shawn Chief Financial Officer | 2026-04-23 | Option exercise 10b5-1 | +12,941 | $16.45 | $212,879 | 118,282 | D |
| Cross Shawn Chief Financial Officer | 2026-04-23 | Sale 10b5-1 | −12,941 | $25.16 | $325,596 | 105,341 | D |
| Derivatives | |||||||
| Cross Shawn Chief Financial Officer | 2026-04-23 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,941 | 150,000 | D | ||
| Open-market sales · 12,941 sh · avg $25.16 · $325,596 | |||||||
Loading xslF345X06/wk-form4_1777077683.xml…